Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment

por Nader-Marta, Guilherme, Molinelli, Chiara, Debien, Véronique, Martins-Branco, Diogo, Aftimos, Philippe, de Azambuja, Evandro, Awada, Ahmad
Publicado 2023

Update on the Management of Breast Cancer during Pregnancy

por Poggio, Francesca, Tagliamento, Marco, Pirrone, Chiara, Soldato, Davide, Conte, Benedetta, Molinelli, Chiara, Cosso, Maurizio, Fregatti, Piero, Del Mastro, Lucia, Lambertini, Matteo
Publicado 2020

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

por Poggio, Francesca, Lambertini, Matteo, Bighin, Claudia, Conte, Benedetta, Blondeaux, Eva, D’Alonzo, Alessia, Dellepiane, Chiara, Buzzatti, Giulia, Molinelli, Chiara, Boccardo, Francesco, Del Mastro, Lucia
Publicado 2019

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

por Blondeaux, Eva, Lambertini, Matteo, Michelotti, Andrea, Conte, Benedetta, Benasso, Marco, Dellepiane, Chiara, Bighin, Claudia, Pastorino, Simona, Levaggi, Alessia, Alonzo, Alessia D’, Poggio, Francesca, Buzzatti, Giulia, Molinelli, Chiara, Fregatti, Piero, Bertoglio, Sergio, Boccardo, Francesco, Del Mastro, Lucia
Publicado 2020

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review

por Garutti, Mattia, Griguolo, Gaia, Botticelli, Andrea, Buzzatti, Giulia, De Angelis, Carmine, Gerratana, Lorenzo, Molinelli, Chiara, Adamo, Vincenzo, Bianchini, Giampaolo, Biganzoli, Laura, Curigliano, Giuseppe, De Laurentiis, Michelino, Fabi, Alessandra, Frassoldati, Antonio, Gennari, Alessandra, Marchiò, Caterina, Perrone, Francesco, Viale, Giuseppe, Zamagni, Claudio, Zambelli, Alberto, Del Mastro, Lucia, De Placido, Sabino, Guarneri, Valentina, Marchetti, Paolo, Puglisi, Fabio
Publicado 2022